Authors

• Markéta Palácová
• Manuela Vaněčková (ORCID: https://orcid.org/0000-0002-8784-7997)
• Jiří Nevrlka (ORCID: https://orcid.org/0000-0002-5286-0630)
• Radka Obermannová (ORCID: https://orcid.org/0000-0001-7363-7879)
• Iveta Selingerová (ORCID: https://orcid.org/0000-0003-3713-3504)
• Lenka Zdražilová Dubská (ORCID: https://orcid.org/0000-0001-6397-0993)
• Igor Kišš (ORCID: https://orcid.org/0000-0001-7693-0659)
• Dalibor Valík (ORCID: https://orcid.org/0000-0003-0922-592X)
• Šárka Selvekerová
• Zdeňka Čermáková (ORCID: https://orcid.org/0000-0002-0859-7409)
• Alexandr Poprach (ORCID: https://orcid.org/0000-0003-4698-9195)
• Regina Demlová (ORCID: https://orcid.org/0000-0002-3797-4453)
• Hana Lejdarová (ORCID: https://orcid.org/0000-0003-1485-2100)
• Kristína Greplová
• Dominika Okruhlicova
• Katerina Cerna-Pilatova

Institutions

• Masaryk University (CZ)
• University Hospital Brno (CZ)
• Masaryk Memorial Cancer Institute (CZ)

Publication Details

Journal

Therapeutic Advances in Medical Oncology

Published

2025-01-01

DOI

https://doi.org/10.1177/17588359251316224

Citations

1

Primary Topic

SARS-CoV-2 and COVID-19 Research

Type

article

Field-Weighted Citation Impact

1.40

Funders

• Roche Diagnostics